Papers
1
Total Citations
2
H-Index
1
About
Kan Li is a leading surgical oncologist whose research focuses on optimizing treatment strategies for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), with particular emphasis on surgical approaches and long-term oncologic outcomes. Her most cited work, "Impact of surgical approach on short- and long-term outcomes in gastroenteropancreatic neuroendocrine carcinomas" (2023), has garnered 2 citations and represents a critical contribution to the field by systematically comparing the efficacy of different surgical techniques in managing these rare but aggressive tumors. Li's research bridges the gap between surgical precision and patient-centered outcomes, providing evidence-based guidance for clinicians facing complex decisions in GEP-NEN management. Her work is particularly notable for its focus on both immediate postoperative recovery and sustained survival benefits, addressing a key unmet need in neuroendocrine tumor surgery. Through rigorous clinical analysis, Li has helped establish benchmarks for surgical quality in this challenging patient population. Her ongoing investigations continue to shape best practices in surgical oncology, making her a respected voice in the multidisciplinary care of neuroendocrine cancer patients.
Research Focus
Key Achievements
Top Papers
- 1